U.K. Medicines Face Six-Month Delay over Brexit 'No-Deal'
U.K. Medicines Face Six-Month Delay over Brexit 'No-Deal'
GALWAY, IRELAND--December 18, 2018--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Fears of a "no-deal" Brexit have prompted the U.K. government's Health Department to call on the pharmaceutical sector to introduce additional measures to ensure supplies of key medicines.
Within this article: Details new U.K. calls for additional medicine stockpiles, reactions from the pharma sector, existing stockpiling initiatives
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects